QuidelOrtho Corporation Files Equity Grant Plans with SEC
1 report, 1 independent
Updated Oct 16
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
QuidelOrtho Corporation approved restricted stock units covering 50,323 common shares for two newly hired non-executive employees. The awards were made under the company’s 2026 Inducement Plan, with the grant date listed as October 15, 2026. The vesting schedule dictates that one-third of the units will vest on October 15, 2027, 2028, and 2029, provided the recipients remain employed.
From econotimes.com
Why it matters
The grants were approved under Nasdaq Listing Rule 5635(c)(4), which permits certain equity awards to induce employment without requiring shareholder approval. The SEC-filed plan requires approval by a majority of independent directors or a compensation committee composed solely of independent directors.
From econotimes.com
Who's involved
Keep exploring
The entities involved
Related events
- IPO filings are subject to SEC oversight, involving the Nasdaq stock exchange and the SEC.
- SEC filing relates to stock traded on Nasdaq.
- The SEC posted a notice regarding a proposed rule change submitted by Nasdaq on October 1, 2026.
- Company Q783794 was listed on the Nasdaq stock exchange.
- Viasat files disclosures with the SEC and its stock trades on the Nasdaq exchange on August 5, 2026.